RECENT FUNDING ROUNDS
Company | Country | Profile | Funding round | Value | Date | |
---|---|---|---|---|---|---|
![]() |
ValenzaBio Inc | antibody for inflammatory eye disease | Series A | USD 70,000,000 | ||
![]() |
Blossomhill Therapeutics Inc | Biotechnology company focused on oncology and autoimmune disorders. | Series A | USD 71,000,000 | ||
![]() |
Perfect Day Inc | Series C | USD 140,000,000 | |||
![]() |
Quell Therapeutics Ltd | Developer of engineered T regulatory cell therapies. | Series A | GBP 35,000,000 | ||
![]() |
Aquaro Histology Inc | Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory. | Series A | USD 9,810,879 | ||
![]() |
3SBio Inc | IPO | HKD 5,510,000,000 | |||
![]() |
Wyeth Pharmaceuticals | Acquisition | USD 68,000,000,000 |
MOST ACTIVE INVESTORS
MOST ACTIVE ACQUIRERS
Pfizer Inc | US | 1 |
BEST FUNDED
Biotechnology company focused on oncology and autoimmune disorders.
Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory.
Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies.
Biotechnology company developing a new class of therapies for metabolic diseases and disorders.